788 related articles for article (PubMed ID: 16038804)
1. Activation and nuclear translocation of ERK1/2 by the formyl peptide receptor is regulated by G protein and is not dependent on beta-arrestin translocation or receptor endocytosis.
Gripentrog JM; Miettinen HM
Cell Signal; 2005 Oct; 17(10):1300-11. PubMed ID: 16038804
[TBL] [Abstract][Full Text] [Related]
2. Formyl peptide receptor-mediated ERK1/2 activation occurs through G(i) and is not dependent on beta-arrestin1/2.
Gripentrog JM; Miettinen HM
Cell Signal; 2008 Feb; 20(2):424-31. PubMed ID: 18060741
[TBL] [Abstract][Full Text] [Related]
3. The role of beta-arrestins in the formyl peptide receptor-like 1 internalization and signaling.
Huet E; Boulay F; Barral S; Rabiet MJ
Cell Signal; 2007 Sep; 19(9):1939-48. PubMed ID: 17594911
[TBL] [Abstract][Full Text] [Related]
4. beta-arrestin-dependent, G protein-independent ERK1/2 activation by the beta2 adrenergic receptor.
Shenoy SK; Drake MT; Nelson CD; Houtz DA; Xiao K; Madabushi S; Reiter E; Premont RT; Lichtarge O; Lefkowitz RJ
J Biol Chem; 2006 Jan; 281(2):1261-73. PubMed ID: 16280323
[TBL] [Abstract][Full Text] [Related]
5. Agonist-dependent phosphorylation of the formyl peptide receptor is regulated by the membrane proximal region of the cytoplasmic tail.
Suvorova ES; Gripentrog JM; Jesaitis AJ; Miettinen HM
Biochim Biophys Acta; 2009 Feb; 1793(2):406-17. PubMed ID: 18952127
[TBL] [Abstract][Full Text] [Related]
6. Receptor sequestration in response to β-arrestin-2 phosphorylation by ERK1/2 governs steady-state levels of GPCR cell-surface expression.
Paradis JS; Ly S; Blondel-Tepaz É; Galan JA; Beautrait A; Scott MG; Enslen H; Marullo S; Roux PP; Bouvier M
Proc Natl Acad Sci U S A; 2015 Sep; 112(37):E5160-8. PubMed ID: 26324936
[TBL] [Abstract][Full Text] [Related]
7. Arrestin binding to the G protein-coupled N-formyl peptide receptor is regulated by the conserved "DRY" sequence.
Bennett TA; Maestas DC; Prossnitz ER
J Biol Chem; 2000 Aug; 275(32):24590-4. PubMed ID: 10823817
[TBL] [Abstract][Full Text] [Related]
8. Constitutive ERK1/2 activation by a chimeric neurokinin 1 receptor-beta-arrestin1 fusion protein. Probing the composition and function of the G protein-coupled receptor "signalsome".
Jafri F; El-Shewy HM; Lee MH; Kelly M; Luttrell DK; Luttrell LM
J Biol Chem; 2006 Jul; 281(28):19346-57. PubMed ID: 16670094
[TBL] [Abstract][Full Text] [Related]
9. Distinct beta-arrestin- and G protein-dependent pathways for parathyroid hormone receptor-stimulated ERK1/2 activation.
Gesty-Palmer D; Chen M; Reiter E; Ahn S; Nelson CD; Wang S; Eckhardt AE; Cowan CL; Spurney RF; Luttrell LM; Lefkowitz RJ
J Biol Chem; 2006 Apr; 281(16):10856-64. PubMed ID: 16492667
[TBL] [Abstract][Full Text] [Related]
10. A single amino acid substitution (N297A) in the conserved NPXXY sequence of the human N-formyl peptide receptor results in inhibition of desensitization and endocytosis, and a dose-dependent shift in p42/44 mitogen-activated protein kinase activation and chemotaxis.
Gripentrog JM; Jesaitis AJ; Miettinen HM
Biochem J; 2000 Dec; 352 Pt 2(Pt 2):399-407. PubMed ID: 11085933
[TBL] [Abstract][Full Text] [Related]
11. Stable interaction between beta-arrestin 2 and angiotensin type 1A receptor is required for beta-arrestin 2-mediated activation of extracellular signal-regulated kinases 1 and 2.
Wei H; Ahn S; Barnes WG; Lefkowitz RJ
J Biol Chem; 2004 Nov; 279(46):48255-61. PubMed ID: 15355986
[TBL] [Abstract][Full Text] [Related]
12. beta-arrestin-dependent endocytosis of proteinase-activated receptor 2 is required for intracellular targeting of activated ERK1/2.
DeFea KA; Zalevsky J; Thoma MS; Déry O; Mullins RD; Bunnett NW
J Cell Biol; 2000 Mar; 148(6):1267-81. PubMed ID: 10725339
[TBL] [Abstract][Full Text] [Related]
13. beta-Arrestin 1 is required for PAC1 receptor-mediated potentiation of long-lasting ERK1/2 activation by glucose in pancreatic beta-cells.
Broca C; Quoyer J; Costes S; Linck N; Varrault A; Deffayet PM; Bockaert J; Dalle S; Bertrand G
J Biol Chem; 2009 Feb; 284(7):4332-42. PubMed ID: 19074139
[TBL] [Abstract][Full Text] [Related]
14. Role of Src in ligand-specific regulation of delta-opioid receptor desensitization and internalization.
Hong MH; Xu C; Wang YJ; Ji JL; Tao YM; Xu XJ; Chen J; Xie X; Chi ZQ; Liu JG
J Neurochem; 2009 Jan; 108(1):102-14. PubMed ID: 19014372
[TBL] [Abstract][Full Text] [Related]
15. Differential effects of beta-arrestins on the internalization, desensitization and ERK1/2 activation downstream of protease activated receptor-2.
Kumar P; Lau CS; Mathur M; Wang P; DeFea KA
Am J Physiol Cell Physiol; 2007 Jul; 293(1):C346-57. PubMed ID: 17442737
[TBL] [Abstract][Full Text] [Related]
16. Regulation of N-Formyl Peptide Receptor Signaling and Trafficking by Arrestin-Src Kinase Interaction.
Wagener BM; Marjon NA; Prossnitz ER
PLoS One; 2016; 11(1):e0147442. PubMed ID: 26788723
[TBL] [Abstract][Full Text] [Related]
17. Identification of putative sites of interaction between the human formyl peptide receptor and G protein.
Miettinen HM; Gripentrog JM; Mason MM; Jesaitis AJ
J Biol Chem; 1999 Sep; 274(39):27934-42. PubMed ID: 10488141
[TBL] [Abstract][Full Text] [Related]
18. Experimental evidence for lack of homodimerization of the G protein-coupled human N-formyl peptide receptor.
Gripentrog JM; Kantele KP; Jesaitis AJ; Miettinen HM
J Immunol; 2003 Sep; 171(6):3187-93. PubMed ID: 12960347
[TBL] [Abstract][Full Text] [Related]
19. beta-Arrestin scaffolding of the ERK cascade enhances cytosolic ERK activity but inhibits ERK-mediated transcription following angiotensin AT1a receptor stimulation.
Tohgo A; Pierce KL; Choy EW; Lefkowitz RJ; Luttrell LM
J Biol Chem; 2002 Mar; 277(11):9429-36. PubMed ID: 11777902
[TBL] [Abstract][Full Text] [Related]
20. The V2 vasopressin receptor stimulates ERK1/2 activity independently of heterotrimeric G protein signalling.
Charest PG; Oligny-Longpré G; Bonin H; Azzi M; Bouvier M
Cell Signal; 2007 Jan; 19(1):32-41. PubMed ID: 16857342
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
